Iridex (IRIX) Net Income towards Common Stockholders (2010 - 2026)
Iridex (IRIX) posted quarterly Net Income towards Common Stockholders of -$524000.0 for Q2 2026, up 68.92% year-over-year from -$310205.1 in Q2 2025, and down 184.78% quarter-over-quarter from -$184000.0 in Q1 2026.
Iridex (IRIX) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Iridex's Net Income towards Common Stockholders history runs 17 years deep, the most recent figure standing at -$524000.0 for Q2 2026.
- In Q2 2026, Net Income towards Common Stockholders rose 68.92% year-over-year to -$524000.0; the TTM figure through Apr 2026 stood at -$3.3 million (up 54.06% YoY), while the FY2026 annual figure was -$4.4 million, up 50.19% from the prior year.
- Net Income towards Common Stockholders for Q2 2026 stood at -$524000.0, down from -$184000.0 in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $6.7 million in Q4 2023, with the low at -$3.5 million in Q1 2024.
- The 5-year median for Net Income towards Common Stockholders is -$1.7 million (2023), against an average of -$713500.0.
- Peak annual rise in Net Income towards Common Stockholders reached 591.46% in 2022, while the deepest fall reached 260.88% in 2022.
- Iridex's Net Income towards Common Stockholders stood at $6.4 million in 2022, then gained by 4.96% to $6.7 million in 2023, then plunged by 112.38% to -$831000.0 in 2024, then tumbled by 89.29% to -$1.6 million in 2025, then soared by 66.69% to -$524000.0 in 2026.
- Business Quant data shows IRIX's Net Income towards Common Stockholders at -$524000.0 in Q2 2026, -$184000.0 in Q1 2026, and -$1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Iridex | 13.34 Mn | 8.66 Mn | 4.30 Mn | -1.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -524,000.00 |
| Jan 3, 2026 | -184,000.00 |
| Sep 27, 2025 | -1.57 Mn |
| Jun 28, 2025 | -994,000.00 |
| Mar 29, 2025 | -1.69 Mn |
| Dec 28, 2024 | -831,000.00 |
| Sep 28, 2024 | -1.93 Mn |
| Jun 29, 2024 | -2.68 Mn |
| Mar 30, 2024 | -3.46 Mn |
| Dec 30, 2023 | 6.71 Mn |
| Sep 30, 2023 | -1.75 Mn |
| Jul 1, 2023 | -2.77 Mn |
| Apr 1, 2023 | -2.09 Mn |
| Dec 31, 2022 | 6.40 Mn |
| Oct 1, 2022 | -1.77 Mn |
| Jul 2, 2022 | -2.24 Mn |
| Apr 2, 2022 | -2.39 Mn |
| Jan 1, 2022 | 925,000.00 |
| Oct 2, 2021 | -2.17 Mn |
| Jul 3, 2021 | 1.39 Mn |